3-[(3R,4R)-4-methyl-3-[methyl({7H-pyrrolo[2,3-d]pyrimidin-4-yl})amino]piperidin-1-yl]-3-oxopropaneni
| Product Name | 3-[(3R,4R)-4-methyl-3-[methyl({7H-pyrrolo[2,3-d]pyrimidin-4-yl})amino]piperidin-1-yl]-3-oxopropaneni |
|---|---|
| Alternate Names | Tofacitinib Impurities, Impurities of Tofacitinib |
| CAT No. | CS-O-36711 |
| CAS No. | Not Available |
| Category | Impurities |
| Stock | Enquire |
| Mol. Wt. | 344.37 g/mol |
| Mol. For. | C16H20N6O3 |
| Hazardous | This is not a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Tofacitinib |
| Smileys | [O-][N+]#CCC(N1C[C@H]([N+](C)([O-])C2=C3C(NC=C3)=NC=N2)[C@H](C)CC1)=O |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
![Picture of 3-[(3R,4R)-4-methyl-3-[methyl({7H-pyrrolo[2,3-d]pyrimidin-4-yl})amino]piperidin-1-yl]-3-oxopropaneni](https://clearsynth.com/structure/3---3R-4R--4-methyl-3--methyl--7H-pyrrolo-2-3-d-pyrimidin-4-yl--amino-piperidin-1-yl--3-oxopropaneni.png)
Get an Instant Quote
Related Compounds
Tofacitinib N-hydroxy impurity | Tofacitinib Nitroso Impurity 2 | Tofacitinib Impurity 36 | Tofacitinib related compound 6 | N,4-dimethyl-1-nitrosopiperidin-3-amine | Tofacitinib Diastereomer | Tofacitinib impurity V | N-methyl-N-(4-methylpyridin-3-yl)nitrous amide | Tofacitinib impurity C | Tofacitinib Nitroso Impurity 1 | N-(1-benzyl-4-methylpiperidin-3-yl)-N-methylnitrous amide | Tofacitinib impurity Z | Tofacitinib N- acid Impurity | Tofacitinib Dihydro Citricacid salt impurity | Tofacitinib Hydroxy Impurity | Tofacitinib Impurity 29 | Tofacitinib impurity N | Tofacitinib- Keto Impurity | Tofacitinib formyl impurity | Tofacitinib N-oxide | Tofacitinib butyl ester impurity | Tofacitinib impurity J | N-methyl-N-(4-methylpiperidin-3-yl)nitrous amide | TOFACITINIB IMPURITY TOF-IV | Tofacitinib impurity K | Tofacitinib Nitroso Impurity | N-Nitroso Tofacitinib Amine Impurity | Tofacitinib Impurity 16 | Tofacitinib Related Compound 29 | Tofacitinib Impurity 57 | Tofacitinib Impurity (N-Des-(2-Cyanide-acetyl)-(3S,4R)) | Tofacitinib S,S Isomer | Tofacitinib impurity I | N-methyl-N-(4-methyl-1-nitrosopiperidin-3-yl)nitrous amide | Tofacitinib Impurity 6 | Tofacitinib Diastereomer-1 and 2 | Tofacitinib Related Compound 26 HCl | Tofacitinib Nitroso Impurity 5 | Tofacitinib Nitroso Impurity 3 | Tofacitinib Dihydro Impurity | Tofacitinib impurity G | Tofacitinib impurity P | Tofacitinib impurity T | Tofacitinib N-Nitroso benzyl intermediate | Tofacitinib Nitroso Impurity 4 |